483
Fareva Unterach GmbHFDA 483 - Fareva Unterach GmbH - May 08, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Ebewe Pharma Ges.m.b.H.Nfg. KG in Unterach am Attersee, Austria, from April 29 to May 8, 2019, revealed significant deficiencies in their manufacturing processes. The firm failed to establish scientifically sound sampling plans for laboratory controls to ensure component quality and purity. Additionally, the written stability testing program was not followed, and electronic records were found to be incomplete and unreliable.
Open in Dashboard
ID · eafed6c0-e57a-49dc-97a4-9f3103956713